nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenoxicam—PTGS1—Ifosfamide—testicular cancer	0.219	0.277	CbGbCtD
Tenoxicam—PTGS2—Cisplatin—testicular cancer	0.126	0.159	CbGbCtD
Tenoxicam—PTGS2—Etoposide—testicular cancer	0.124	0.157	CbGbCtD
Tenoxicam—PTGS1—Etoposide—testicular cancer	0.105	0.132	CbGbCtD
Tenoxicam—CYP2C9—Ifosfamide—testicular cancer	0.0882	0.111	CbGbCtD
Tenoxicam—SLC22A8—Methotrexate—testicular cancer	0.0871	0.11	CbGbCtD
Tenoxicam—CYP2C9—Cisplatin—testicular cancer	0.0429	0.0542	CbGbCtD
Tenoxicam—Erythema multiforme—Etoposide—testicular cancer	0.000663	0.00319	CcSEcCtD
Tenoxicam—Dyspnoea—Bleomycin—testicular cancer	0.000658	0.00316	CcSEcCtD
Tenoxicam—Anorexia—Dactinomycin—testicular cancer	0.000656	0.00316	CcSEcCtD
Tenoxicam—Eye disorder—Etoposide—testicular cancer	0.000655	0.00315	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000654	0.00314	CcSEcCtD
Tenoxicam—Diarrhoea—Chlorambucil—testicular cancer	0.000653	0.00314	CcSEcCtD
Tenoxicam—Cardiac disorder—Etoposide—testicular cancer	0.000651	0.00313	CcSEcCtD
Tenoxicam—Hypersensitivity—Vinblastine—testicular cancer	0.000644	0.0031	CcSEcCtD
Tenoxicam—Decreased appetite—Bleomycin—testicular cancer	0.000642	0.00309	CcSEcCtD
Tenoxicam—Visual disturbance—Methotrexate—testicular cancer	0.000641	0.00308	CcSEcCtD
Tenoxicam—Angiopathy—Etoposide—testicular cancer	0.000636	0.00306	CcSEcCtD
Tenoxicam—Immune system disorder—Etoposide—testicular cancer	0.000633	0.00305	CcSEcCtD
Tenoxicam—Anaphylactic shock—Ifosfamide—testicular cancer	0.000631	0.00303	CcSEcCtD
Tenoxicam—Oedema—Ifosfamide—testicular cancer	0.000631	0.00303	CcSEcCtD
Tenoxicam—Asthenia—Vinblastine—testicular cancer	0.000627	0.00302	CcSEcCtD
Tenoxicam—Nervous system disorder—Ifosfamide—testicular cancer	0.000619	0.00297	CcSEcCtD
Tenoxicam—Thrombocytopenia—Ifosfamide—testicular cancer	0.000618	0.00297	CcSEcCtD
Tenoxicam—Anaemia—Cisplatin—testicular cancer	0.000616	0.00296	CcSEcCtD
Tenoxicam—Skin disorder—Ifosfamide—testicular cancer	0.000613	0.00295	CcSEcCtD
Tenoxicam—Vomiting—Chlorambucil—testicular cancer	0.000606	0.00292	CcSEcCtD
Tenoxicam—Anorexia—Ifosfamide—testicular cancer	0.000601	0.00289	CcSEcCtD
Tenoxicam—Decreased appetite—Dactinomycin—testicular cancer	0.000598	0.00288	CcSEcCtD
Tenoxicam—Diarrhoea—Vinblastine—testicular cancer	0.000598	0.00288	CcSEcCtD
Tenoxicam—Leukopenia—Cisplatin—testicular cancer	0.000597	0.00287	CcSEcCtD
Tenoxicam—Fatigue—Dactinomycin—testicular cancer	0.000594	0.00285	CcSEcCtD
Tenoxicam—Urticaria—Bleomycin—testicular cancer	0.000586	0.00282	CcSEcCtD
Tenoxicam—Cardiac failure—Epirubicin—testicular cancer	0.000582	0.0028	CcSEcCtD
Tenoxicam—Dizziness—Vinblastine—testicular cancer	0.000578	0.00278	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.000568	0.00273	CcSEcCtD
Tenoxicam—Nausea—Chlorambucil—testicular cancer	0.000567	0.00272	CcSEcCtD
Tenoxicam—Anaemia—Etoposide—testicular cancer	0.000564	0.00271	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000563	0.00271	CcSEcCtD
Tenoxicam—Dyspnoea—Ifosfamide—testicular cancer	0.000562	0.0027	CcSEcCtD
Tenoxicam—Vomiting—Vinblastine—testicular cancer	0.000556	0.00267	CcSEcCtD
Tenoxicam—Breast disorder—Methotrexate—testicular cancer	0.000549	0.00264	CcSEcCtD
Tenoxicam—Vertigo—Etoposide—testicular cancer	0.000549	0.00264	CcSEcCtD
Tenoxicam—Decreased appetite—Ifosfamide—testicular cancer	0.000548	0.00264	CcSEcCtD
Tenoxicam—Headache—Vinblastine—testicular cancer	0.000548	0.00263	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000547	0.00263	CcSEcCtD
Tenoxicam—Leukopenia—Etoposide—testicular cancer	0.000547	0.00263	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000545	0.00262	CcSEcCtD
Tenoxicam—Fatigue—Ifosfamide—testicular cancer	0.000544	0.00262	CcSEcCtD
Tenoxicam—Anaphylactic shock—Cisplatin—testicular cancer	0.000544	0.00262	CcSEcCtD
Tenoxicam—Oedema—Cisplatin—testicular cancer	0.000544	0.00262	CcSEcCtD
Tenoxicam—Hypersensitivity—Bleomycin—testicular cancer	0.000544	0.00261	CcSEcCtD
Tenoxicam—Constipation—Ifosfamide—testicular cancer	0.00054	0.00259	CcSEcCtD
Tenoxicam—Cardiac failure—Doxorubicin—testicular cancer	0.000539	0.00259	CcSEcCtD
Tenoxicam—Nervous system disorder—Cisplatin—testicular cancer	0.000533	0.00256	CcSEcCtD
Tenoxicam—Thrombocytopenia—Cisplatin—testicular cancer	0.000533	0.00256	CcSEcCtD
Tenoxicam—Asthenia—Bleomycin—testicular cancer	0.00053	0.00255	CcSEcCtD
Tenoxicam—Skin disorder—Cisplatin—testicular cancer	0.000528	0.00254	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.000526	0.00253	CcSEcCtD
Tenoxicam—Asthma—Methotrexate—testicular cancer	0.000525	0.00252	CcSEcCtD
Tenoxicam—Pruritus—Bleomycin—testicular cancer	0.000522	0.00251	CcSEcCtD
Tenoxicam—Nausea—Vinblastine—testicular cancer	0.000519	0.0025	CcSEcCtD
Tenoxicam—Anorexia—Cisplatin—testicular cancer	0.000518	0.00249	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000516	0.00248	CcSEcCtD
Tenoxicam—Breast disorder—Epirubicin—testicular cancer	0.000514	0.00247	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000512	0.00246	CcSEcCtD
Tenoxicam—Hypersensitivity—Dactinomycin—testicular cancer	0.000507	0.00244	CcSEcCtD
Tenoxicam—Abdominal discomfort—Methotrexate—testicular cancer	0.000503	0.00242	CcSEcCtD
Tenoxicam—Gastritis—Epirubicin—testicular cancer	0.000503	0.00242	CcSEcCtD
Tenoxicam—Urticaria—Ifosfamide—testicular cancer	0.000501	0.00241	CcSEcCtD
Tenoxicam—Anaphylactic shock—Etoposide—testicular cancer	0.000498	0.0024	CcSEcCtD
Tenoxicam—Asthenia—Dactinomycin—testicular cancer	0.000494	0.00237	CcSEcCtD
Tenoxicam—Asthma—Epirubicin—testicular cancer	0.000491	0.00236	CcSEcCtD
Tenoxicam—Thrombocytopenia—Etoposide—testicular cancer	0.000488	0.00235	CcSEcCtD
Tenoxicam—Dyspnoea—Cisplatin—testicular cancer	0.000485	0.00233	CcSEcCtD
Tenoxicam—Skin disorder—Etoposide—testicular cancer	0.000484	0.00233	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Methotrexate—testicular cancer	0.000479	0.0023	CcSEcCtD
Tenoxicam—Breast disorder—Doxorubicin—testicular cancer	0.000475	0.00228	CcSEcCtD
Tenoxicam—Anorexia—Etoposide—testicular cancer	0.000475	0.00228	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000474	0.00228	CcSEcCtD
Tenoxicam—Decreased appetite—Cisplatin—testicular cancer	0.000473	0.00227	CcSEcCtD
Tenoxicam—Diarrhoea—Dactinomycin—testicular cancer	0.000471	0.00226	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00047	0.00226	CcSEcCtD
Tenoxicam—Vomiting—Bleomycin—testicular cancer	0.000469	0.00226	CcSEcCtD
Tenoxicam—Rash—Bleomycin—testicular cancer	0.000465	0.00224	CcSEcCtD
Tenoxicam—Gastritis—Doxorubicin—testicular cancer	0.000465	0.00224	CcSEcCtD
Tenoxicam—Dermatitis—Bleomycin—testicular cancer	0.000465	0.00224	CcSEcCtD
Tenoxicam—Hypersensitivity—Ifosfamide—testicular cancer	0.000465	0.00223	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000464	0.00223	CcSEcCtD
Tenoxicam—Stomatitis—Methotrexate—testicular cancer	0.000456	0.00219	CcSEcCtD
Tenoxicam—Asthma—Doxorubicin—testicular cancer	0.000454	0.00219	CcSEcCtD
Tenoxicam—Asthenia—Ifosfamide—testicular cancer	0.000453	0.00218	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Epirubicin—testicular cancer	0.000448	0.00216	CcSEcCtD
Tenoxicam—Pruritus—Ifosfamide—testicular cancer	0.000446	0.00215	CcSEcCtD
Tenoxicam—Dyspnoea—Etoposide—testicular cancer	0.000444	0.00214	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Methotrexate—testicular cancer	0.000443	0.00213	CcSEcCtD
Tenoxicam—Nausea—Bleomycin—testicular cancer	0.000438	0.00211	CcSEcCtD
Tenoxicam—Vomiting—Dactinomycin—testicular cancer	0.000438	0.0021	CcSEcCtD
Tenoxicam—Agranulocytosis—Methotrexate—testicular cancer	0.000437	0.0021	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000434	0.00209	CcSEcCtD
Tenoxicam—Rash—Dactinomycin—testicular cancer	0.000434	0.00209	CcSEcCtD
Tenoxicam—Decreased appetite—Etoposide—testicular cancer	0.000433	0.00208	CcSEcCtD
Tenoxicam—Diarrhoea—Ifosfamide—testicular cancer	0.000432	0.00208	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Etoposide—testicular cancer	0.00043	0.00207	CcSEcCtD
Tenoxicam—Fatigue—Etoposide—testicular cancer	0.00043	0.00207	CcSEcCtD
Tenoxicam—Stomatitis—Epirubicin—testicular cancer	0.000427	0.00205	CcSEcCtD
Tenoxicam—Constipation—Etoposide—testicular cancer	0.000426	0.00205	CcSEcCtD
Tenoxicam—Hepatitis—Methotrexate—testicular cancer	0.00042	0.00202	CcSEcCtD
Tenoxicam—Dizziness—Ifosfamide—testicular cancer	0.000417	0.00201	CcSEcCtD
Tenoxicam—Urinary tract disorder—Methotrexate—testicular cancer	0.000415	0.00199	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000415	0.00199	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Epirubicin—testicular cancer	0.000414	0.00199	CcSEcCtD
Tenoxicam—Urethral disorder—Methotrexate—testicular cancer	0.000412	0.00198	CcSEcCtD
Tenoxicam—Nausea—Dactinomycin—testicular cancer	0.000409	0.00197	CcSEcCtD
Tenoxicam—Agranulocytosis—Epirubicin—testicular cancer	0.000409	0.00196	CcSEcCtD
Tenoxicam—Visual impairment—Methotrexate—testicular cancer	0.000405	0.00195	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000402	0.00193	CcSEcCtD
Tenoxicam—Vomiting—Ifosfamide—testicular cancer	0.000401	0.00193	CcSEcCtD
Tenoxicam—Hypersensitivity—Cisplatin—testicular cancer	0.000401	0.00193	CcSEcCtD
Tenoxicam—Rash—Ifosfamide—testicular cancer	0.000398	0.00191	CcSEcCtD
Tenoxicam—Dermatitis—Ifosfamide—testicular cancer	0.000397	0.00191	CcSEcCtD
Tenoxicam—Erythema multiforme—Methotrexate—testicular cancer	0.000397	0.00191	CcSEcCtD
Tenoxicam—Urticaria—Etoposide—testicular cancer	0.000396	0.0019	CcSEcCtD
Tenoxicam—Stomatitis—Doxorubicin—testicular cancer	0.000395	0.0019	CcSEcCtD
Tenoxicam—Hepatitis—Epirubicin—testicular cancer	0.000393	0.00189	CcSEcCtD
Tenoxicam—Eye disorder—Methotrexate—testicular cancer	0.000393	0.00189	CcSEcCtD
Tenoxicam—Asthenia—Cisplatin—testicular cancer	0.00039	0.00188	CcSEcCtD
Tenoxicam—Cardiac disorder—Methotrexate—testicular cancer	0.00039	0.00187	CcSEcCtD
Tenoxicam—Urinary tract disorder—Epirubicin—testicular cancer	0.000388	0.00187	CcSEcCtD
Tenoxicam—Urethral disorder—Epirubicin—testicular cancer	0.000385	0.00185	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000383	0.00184	CcSEcCtD
Tenoxicam—Angiopathy—Methotrexate—testicular cancer	0.000381	0.00183	CcSEcCtD
Tenoxicam—Immune system disorder—Methotrexate—testicular cancer	0.000379	0.00182	CcSEcCtD
Tenoxicam—Visual impairment—Epirubicin—testicular cancer	0.000379	0.00182	CcSEcCtD
Tenoxicam—Agranulocytosis—Doxorubicin—testicular cancer	0.000378	0.00182	CcSEcCtD
Tenoxicam—Nausea—Ifosfamide—testicular cancer	0.000375	0.0018	CcSEcCtD
Tenoxicam—Diarrhoea—Cisplatin—testicular cancer	0.000372	0.00179	CcSEcCtD
Tenoxicam—Erythema multiforme—Epirubicin—testicular cancer	0.000372	0.00179	CcSEcCtD
Tenoxicam—Mental disorder—Methotrexate—testicular cancer	0.000368	0.00177	CcSEcCtD
Tenoxicam—Eye disorder—Epirubicin—testicular cancer	0.000367	0.00177	CcSEcCtD
Tenoxicam—Hypersensitivity—Etoposide—testicular cancer	0.000367	0.00177	CcSEcCtD
Tenoxicam—Erythema—Methotrexate—testicular cancer	0.000366	0.00176	CcSEcCtD
Tenoxicam—Malnutrition—Methotrexate—testicular cancer	0.000366	0.00176	CcSEcCtD
Tenoxicam—Cardiac disorder—Epirubicin—testicular cancer	0.000365	0.00175	CcSEcCtD
Tenoxicam—Hepatitis—Doxorubicin—testicular cancer	0.000364	0.00175	CcSEcCtD
Tenoxicam—Urinary tract disorder—Doxorubicin—testicular cancer	0.000359	0.00173	CcSEcCtD
Tenoxicam—Asthenia—Etoposide—testicular cancer	0.000358	0.00172	CcSEcCtD
Tenoxicam—Angiopathy—Epirubicin—testicular cancer	0.000357	0.00171	CcSEcCtD
Tenoxicam—Urethral disorder—Doxorubicin—testicular cancer	0.000357	0.00171	CcSEcCtD
Tenoxicam—Immune system disorder—Epirubicin—testicular cancer	0.000355	0.00171	CcSEcCtD
Tenoxicam—Pruritus—Etoposide—testicular cancer	0.000353	0.00169	CcSEcCtD
Tenoxicam—Visual impairment—Doxorubicin—testicular cancer	0.000351	0.00169	CcSEcCtD
Tenoxicam—Vomiting—Cisplatin—testicular cancer	0.000346	0.00166	CcSEcCtD
Tenoxicam—Mental disorder—Epirubicin—testicular cancer	0.000344	0.00166	CcSEcCtD
Tenoxicam—Erythema multiforme—Doxorubicin—testicular cancer	0.000344	0.00165	CcSEcCtD
Tenoxicam—Rash—Cisplatin—testicular cancer	0.000343	0.00165	CcSEcCtD
Tenoxicam—Dermatitis—Cisplatin—testicular cancer	0.000343	0.00165	CcSEcCtD
Tenoxicam—Erythema—Epirubicin—testicular cancer	0.000342	0.00165	CcSEcCtD
Tenoxicam—Malnutrition—Epirubicin—testicular cancer	0.000342	0.00165	CcSEcCtD
Tenoxicam—Diarrhoea—Etoposide—testicular cancer	0.000341	0.00164	CcSEcCtD
Tenoxicam—Eye disorder—Doxorubicin—testicular cancer	0.00034	0.00163	CcSEcCtD
Tenoxicam—Anaemia—Methotrexate—testicular cancer	0.000338	0.00163	CcSEcCtD
Tenoxicam—Cardiac disorder—Doxorubicin—testicular cancer	0.000338	0.00162	CcSEcCtD
Tenoxicam—Angiopathy—Doxorubicin—testicular cancer	0.00033	0.00159	CcSEcCtD
Tenoxicam—Dizziness—Etoposide—testicular cancer	0.00033	0.00158	CcSEcCtD
Tenoxicam—Immune system disorder—Doxorubicin—testicular cancer	0.000329	0.00158	CcSEcCtD
Tenoxicam—Vertigo—Methotrexate—testicular cancer	0.000329	0.00158	CcSEcCtD
Tenoxicam—Leukopenia—Methotrexate—testicular cancer	0.000327	0.00157	CcSEcCtD
Tenoxicam—Nausea—Cisplatin—testicular cancer	0.000323	0.00155	CcSEcCtD
Tenoxicam—Mental disorder—Doxorubicin—testicular cancer	0.000319	0.00153	CcSEcCtD
Tenoxicam—Vomiting—Etoposide—testicular cancer	0.000317	0.00152	CcSEcCtD
Tenoxicam—Erythema—Doxorubicin—testicular cancer	0.000317	0.00152	CcSEcCtD
Tenoxicam—Malnutrition—Doxorubicin—testicular cancer	0.000317	0.00152	CcSEcCtD
Tenoxicam—Anaemia—Epirubicin—testicular cancer	0.000316	0.00152	CcSEcCtD
Tenoxicam—Rash—Etoposide—testicular cancer	0.000314	0.00151	CcSEcCtD
Tenoxicam—Dermatitis—Etoposide—testicular cancer	0.000314	0.00151	CcSEcCtD
Tenoxicam—Headache—Etoposide—testicular cancer	0.000312	0.0015	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000309	0.00149	CcSEcCtD
Tenoxicam—Vertigo—Epirubicin—testicular cancer	0.000307	0.00148	CcSEcCtD
Tenoxicam—Leukopenia—Epirubicin—testicular cancer	0.000306	0.00147	CcSEcCtD
Tenoxicam—Palpitations—Epirubicin—testicular cancer	0.000302	0.00145	CcSEcCtD
Tenoxicam—Anaphylactic shock—Methotrexate—testicular cancer	0.000298	0.00144	CcSEcCtD
Tenoxicam—Nausea—Etoposide—testicular cancer	0.000296	0.00142	CcSEcCtD
Tenoxicam—Nervous system disorder—Methotrexate—testicular cancer	0.000293	0.00141	CcSEcCtD
Tenoxicam—Anaemia—Doxorubicin—testicular cancer	0.000293	0.00141	CcSEcCtD
Tenoxicam—Thrombocytopenia—Methotrexate—testicular cancer	0.000292	0.00141	CcSEcCtD
Tenoxicam—Skin disorder—Methotrexate—testicular cancer	0.00029	0.00139	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000289	0.00139	CcSEcCtD
Tenoxicam—Dry mouth—Epirubicin—testicular cancer	0.000285	0.00137	CcSEcCtD
Tenoxicam—Vertigo—Doxorubicin—testicular cancer	0.000285	0.00137	CcSEcCtD
Tenoxicam—Anorexia—Methotrexate—testicular cancer	0.000284	0.00137	CcSEcCtD
Tenoxicam—Leukopenia—Doxorubicin—testicular cancer	0.000283	0.00136	CcSEcCtD
Tenoxicam—Palpitations—Doxorubicin—testicular cancer	0.00028	0.00135	CcSEcCtD
Tenoxicam—Anaphylactic shock—Epirubicin—testicular cancer	0.000279	0.00134	CcSEcCtD
Tenoxicam—Oedema—Epirubicin—testicular cancer	0.000279	0.00134	CcSEcCtD
Tenoxicam—Nervous system disorder—Epirubicin—testicular cancer	0.000274	0.00132	CcSEcCtD
Tenoxicam—Thrombocytopenia—Epirubicin—testicular cancer	0.000273	0.00131	CcSEcCtD
Tenoxicam—Skin disorder—Epirubicin—testicular cancer	0.000271	0.0013	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000268	0.00129	CcSEcCtD
Tenoxicam—Anorexia—Epirubicin—testicular cancer	0.000266	0.00128	CcSEcCtD
Tenoxicam—Dyspnoea—Methotrexate—testicular cancer	0.000266	0.00128	CcSEcCtD
Tenoxicam—Dry mouth—Doxorubicin—testicular cancer	0.000264	0.00127	CcSEcCtD
Tenoxicam—Dyspepsia—Methotrexate—testicular cancer	0.000263	0.00126	CcSEcCtD
Tenoxicam—Decreased appetite—Methotrexate—testicular cancer	0.000259	0.00125	CcSEcCtD
Tenoxicam—Anaphylactic shock—Doxorubicin—testicular cancer	0.000258	0.00124	CcSEcCtD
Tenoxicam—Oedema—Doxorubicin—testicular cancer	0.000258	0.00124	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000258	0.00124	CcSEcCtD
Tenoxicam—Fatigue—Methotrexate—testicular cancer	0.000257	0.00124	CcSEcCtD
Tenoxicam—Nervous system disorder—Doxorubicin—testicular cancer	0.000253	0.00122	CcSEcCtD
Tenoxicam—Thrombocytopenia—Doxorubicin—testicular cancer	0.000253	0.00122	CcSEcCtD
Tenoxicam—Skin disorder—Doxorubicin—testicular cancer	0.000251	0.00121	CcSEcCtD
Tenoxicam—Dyspnoea—Epirubicin—testicular cancer	0.000249	0.0012	CcSEcCtD
Tenoxicam—Anorexia—Doxorubicin—testicular cancer	0.000246	0.00118	CcSEcCtD
Tenoxicam—Dyspepsia—Epirubicin—testicular cancer	0.000246	0.00118	CcSEcCtD
Tenoxicam—Decreased appetite—Epirubicin—testicular cancer	0.000243	0.00117	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000241	0.00116	CcSEcCtD
Tenoxicam—Fatigue—Epirubicin—testicular cancer	0.000241	0.00116	CcSEcCtD
Tenoxicam—Constipation—Epirubicin—testicular cancer	0.000239	0.00115	CcSEcCtD
Tenoxicam—Urticaria—Methotrexate—testicular cancer	0.000237	0.00114	CcSEcCtD
Tenoxicam—Dyspnoea—Doxorubicin—testicular cancer	0.00023	0.00111	CcSEcCtD
Tenoxicam—Dyspepsia—Doxorubicin—testicular cancer	0.000227	0.00109	CcSEcCtD
Tenoxicam—Decreased appetite—Doxorubicin—testicular cancer	0.000225	0.00108	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000223	0.00107	CcSEcCtD
Tenoxicam—Fatigue—Doxorubicin—testicular cancer	0.000223	0.00107	CcSEcCtD
Tenoxicam—Urticaria—Epirubicin—testicular cancer	0.000222	0.00107	CcSEcCtD
Tenoxicam—Constipation—Doxorubicin—testicular cancer	0.000221	0.00106	CcSEcCtD
Tenoxicam—Hypersensitivity—Methotrexate—testicular cancer	0.00022	0.00106	CcSEcCtD
Tenoxicam—Asthenia—Methotrexate—testicular cancer	0.000214	0.00103	CcSEcCtD
Tenoxicam—Pruritus—Methotrexate—testicular cancer	0.000211	0.00102	CcSEcCtD
Tenoxicam—Hypersensitivity—Epirubicin—testicular cancer	0.000206	0.000989	CcSEcCtD
Tenoxicam—Urticaria—Doxorubicin—testicular cancer	0.000205	0.000987	CcSEcCtD
Tenoxicam—Diarrhoea—Methotrexate—testicular cancer	0.000204	0.000982	CcSEcCtD
Tenoxicam—Asthenia—Epirubicin—testicular cancer	0.0002	0.000964	CcSEcCtD
Tenoxicam—Pruritus—Epirubicin—testicular cancer	0.000198	0.00095	CcSEcCtD
Tenoxicam—Dizziness—Methotrexate—testicular cancer	0.000197	0.000949	CcSEcCtD
Tenoxicam—Diarrhoea—Epirubicin—testicular cancer	0.000191	0.000919	CcSEcCtD
Tenoxicam—Hypersensitivity—Doxorubicin—testicular cancer	0.00019	0.000915	CcSEcCtD
Tenoxicam—Vomiting—Methotrexate—testicular cancer	0.00019	0.000912	CcSEcCtD
Tenoxicam—Rash—Methotrexate—testicular cancer	0.000188	0.000905	CcSEcCtD
Tenoxicam—Dermatitis—Methotrexate—testicular cancer	0.000188	0.000904	CcSEcCtD
Tenoxicam—Headache—Methotrexate—testicular cancer	0.000187	0.000899	CcSEcCtD
Tenoxicam—Asthenia—Doxorubicin—testicular cancer	0.000185	0.000892	CcSEcCtD
Tenoxicam—Dizziness—Epirubicin—testicular cancer	0.000185	0.000888	CcSEcCtD
Tenoxicam—Pruritus—Doxorubicin—testicular cancer	0.000183	0.000879	CcSEcCtD
Tenoxicam—Vomiting—Epirubicin—testicular cancer	0.000178	0.000854	CcSEcCtD
Tenoxicam—Nausea—Methotrexate—testicular cancer	0.000177	0.000852	CcSEcCtD
Tenoxicam—Diarrhoea—Doxorubicin—testicular cancer	0.000177	0.00085	CcSEcCtD
Tenoxicam—Rash—Epirubicin—testicular cancer	0.000176	0.000847	CcSEcCtD
Tenoxicam—Dermatitis—Epirubicin—testicular cancer	0.000176	0.000846	CcSEcCtD
Tenoxicam—Headache—Epirubicin—testicular cancer	0.000175	0.000841	CcSEcCtD
Tenoxicam—Dizziness—Doxorubicin—testicular cancer	0.000171	0.000822	CcSEcCtD
Tenoxicam—Nausea—Epirubicin—testicular cancer	0.000166	0.000798	CcSEcCtD
Tenoxicam—Vomiting—Doxorubicin—testicular cancer	0.000164	0.00079	CcSEcCtD
Tenoxicam—Rash—Doxorubicin—testicular cancer	0.000163	0.000783	CcSEcCtD
Tenoxicam—Dermatitis—Doxorubicin—testicular cancer	0.000163	0.000783	CcSEcCtD
Tenoxicam—Headache—Doxorubicin—testicular cancer	0.000162	0.000778	CcSEcCtD
Tenoxicam—Nausea—Doxorubicin—testicular cancer	0.000154	0.000738	CcSEcCtD
